| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
SPTX
Seaport Therapeutics, Inc.
|
Aug 25, 2026 | BUY |
Strong Buy
+41.6% avg upside
7 analysts
|
$32.00
23.29% Upside
|
· | · |
|
RNXT
RenovoRx
|
Aug 19, 2026 | BUY |
Strong Buy
+327.2% avg upside
5 analysts
|
$8.00
414.56% Upside
|
+12.6% | · |
|
CLNN
Clene
|
Aug 18, 2026 | BUY |
Strong Buy
+628.1% avg upside
11 analysts
|
$30.00
563.74% Upside
|
+5.6% | · |
|
NMTC
NeuroOne Medical Technologies
|
Aug 18, 2026 | BUY |
Strong Buy
+227.9% avg upside
5 analysts
|
$8.00
357.05% Upside
|
+8.0% | · |
|
SER
Serina Therapeutics
|
Aug 18, 2026 | BUY |
Strong Buy
+339.6% avg upside
3 analysts
|
$11.00
339.94% Upside
|
+9.5% | · |
|
ATNM
Actinium Pharmaceuticals
|
Aug 14, 2026 | BUY |
Strong Buy
+583.4% avg upside
11 analysts
|
$3.00
196.88% Upside
|
+5.8% | · |
|
LNTH
Lantheus
|
Aug 14, 2026 | HOLD |
Buy
-19.5% avg upside
21 analysts
|
— | -0.1% | · |
|
CATX
Perspective Therapeutics
|
Aug 14, 2026 | BUY |
Strong Buy
+248.1% avg upside
22 analysts
|
$18.00
480.69% Upside
|
-1.2% | · |
|
DFTX
Definium Therapeutics
|
Aug 13, 2026 | BUY |
Strong Buy
+18.6% avg upside
22 analysts
|
$90.00
113.14% Upside
|
-0.3% | · |
|
TLSI
TriSalus Life Sciences
|
Aug 10, 2026 | BUY |
Strong Buy
+99.1% avg upside
8 analysts
|
$11.00
133.84% Upside
|
-8.4% | · |
|
PRAX
Praxis Precision Medicines
|
Aug 07, 2026 | BUY |
Strong Buy
+51.0% avg upside
24 analysts
|
$441.00
24.88% Upside
|
+2.0% | · |
|
RAPP
Rapport Therapeutics, Inc.
|
Aug 06, 2026 | BUY |
Strong Buy
+14.7% avg upside
14 analysts
|
$50.00
1.14% Upside
|
+9.7% | · |
|
XAIR
Beyond Air
|
Jul 31, 2026 | HOLD |
Strong Buy
+1725.0% avg upside
10 analysts
|
— | -4.5% | · |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Jul 31, 2026 | HOLD |
Strong Buy
+247.6% avg upside
6 analysts
|
— | -0.4% | · |
|
ATAI
Atai Beckley N.V.
|
Jul 16, 2026 | HOLD |
Buy
+23.0% avg upside
17 analysts
|
— | +3.2% | · |
|
ANRO
Alto Neuroscience, Inc.
|
Jun 26, 2026 | BUY |
Strong Buy
-11.7% avg upside
13 analysts
|
$44.00
25.19% Upside
|
+34.1% | · |
|
VNRX
VolitionRX
|
May 18, 2026 | BUY |
Strong Buy
+1946.4% avg upside
11 analysts
|
$24.00
5288.37% Upside
|
-81.6% | · |
|
ACHV
Achieve Life Sciences
|
May 12, 2026 | BUY |
Strong Buy
+87.7% avg upside
15 analysts
|
$20.00
148.49% Upside
|
+36.4% | · |
|
RADX
Radiopharm Theranostics Limited Sponsored ADR
|
Mar 25, 2026 | BUY |
Strong Buy
+675.8% avg upside
6 analysts
|
$30.00
1032.12% Upside
|
-43.6% | · |
|
VOR
Vor Biopharma
|
Jan 05, 2026 | HOLD |
Buy
+87.5% avg upside
17 analysts
|
— | +120.8% | · |
|
MNPR
Monopar Therapeutics Inc
|
May 14, 2025 | HOLD |
Strong Buy
-9.6% avg upside
18 analysts
|
— | +64.3% | · |
|
CNSY
Cerenome
|
Mar 21, 2025 | HOLD |
Strong Buy
+937.2% avg upside
11 analysts
|
— | -78.8% | · |
|
AU:RAD
Radiopharm Theranostics Limited
|
Oct 30, 2024 | BUY |
Strong Buy
+4344.4% avg upside
1 analyst
|
$0.40
4344.39% Upside
|
+0.0% | · |
|
PRME
Prime Medicine, Inc.
|
Aug 08, 2024 | BUY |
Strong Buy
+167.0% avg upside
17 analysts
|
$20.00
473.02% Upside
|
-13.8% | · |
|
QUCY
Quantum Cyber
|
Jun 04, 2024 | BUY |
Buy
+172.1% avg upside
4 analysts
|
$4.00
172.13% Upside
|
+181.0% | · |
|
CRIS
Curis
|
Jun 06, 2022 | BUY |
Strong Buy
+762.6% avg upside
12 analysts
|
$10.00
549.43% Upside
|
· | · |
|
GTBP
GT Biopharma
|
May 19, 2022 | BUY |
Strong Buy
+3373.2% avg upside
3 analysts
|
$18.00
5852.37% Upside
|
· | · |
|
HROW
Harrow Health
|
May 19, 2022 | BUY |
Strong Buy
+40.3% avg upside
12 analysts
|
$20.00
46.79% Downside
|
+269.5% | · |
|
CMPX
Compass Therapeutics
|
May 10, 2022 | BUY |
Strong Buy
+283.1% avg upside
20 analysts
|
$10.00
306.60% Upside
|
+105.5% | · |
|
CTSO
Cytosorbents
|
May 04, 2022 | BUY |
Strong Buy
+3375.7% avg upside
13 analysts
|
$6.00
1775.06% Upside
|
+30.2% | · |
|
ETON
Eton Pharmaceuticals
|
Apr 07, 2022 | BUY |
Strong Buy
-39.7% avg upside
9 analysts
|
$10.00
83.33% Downside
|
-15.5% | · |
|
VRAYQ
Viewray
|
Jan 11, 2022 | BUY |
Strong Buy
+558333233.3% avg upside
12 analysts
|
$7.00
699999899.97% Upside
|
· | · |
|
FOCL
FocalTherics
|
Nov 26, 2021 | HOLD |
Buy
+95.7% avg upside
8 analysts
|
— | +93.5% | · |
|
PGEN
Precigen
|
Nov 26, 2021 | HOLD |
Strong Buy
+243.3% avg upside
11 analysts
|
— | -50.3% | · |
|
SNDX
Syndax Pharmaceuticals
|
Nov 17, 2021 | BUY |
Strong Buy
+74.4% avg upside
27 analysts
|
$30.00
53.32% Upside
|
+18.6% | · |
|
ALP
Alpha Compute
|
Sep 02, 2021 | BUY |
Strong Buy
+9662.4% avg upside
7 analysts
|
$40.00
23709.46% Upside
|
· | · |
|
GERN
Geron
|
Feb 17, 2021 | BUY |
Strong Buy
+180.0% avg upside
19 analysts
|
$4.00
164.05% Upside
|
-48.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.